Mark H. Breedlove - Net Worth and Insider Trading
Mark H. Breedlove Net Worth
The estimated net worth of Mark H. Breedlove is at least $246,571 dollars as of 2024-11-13. Mark H. Breedlove is the Director of Cognition Therapeutics Inc and owns about 412,050 shares of Cognition Therapeutics Inc (CGTX) stock worth over $246,571. Details can be seen in Mark H. Breedlove's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark H. Breedlove has not made any transactions after 2021-10-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark H. Breedlove
Mark H. Breedlove Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark H. Breedlove owns 1 companies in total, including Cognition Therapeutics Inc (CGTX) .
Click here to see the complete history of Mark H. Breedlove’s form 4 insider trades.
Insider Ownership Summary of Mark H. Breedlove
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CGTX | Cognition Therapeutics Inc | 2021-10-13 | director |
Mark H. Breedlove Latest Holdings Summary
Mark H. Breedlove currently owns a total of 1 stock. Mark H. Breedlove owns 412,050 shares of Cognition Therapeutics Inc (CGTX) as of October 13, 2021, with a value of $246,571.
Latest Holdings of Mark H. Breedlove
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CGTX | Cognition Therapeutics Inc | 2021-10-13 | 412,050 | 0.60 | 246,571 |
Holding Weightings of Mark H. Breedlove
Mark H. Breedlove Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark H. Breedlove has made a total of 1 transactions in Cognition Therapeutics Inc (CGTX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Cognition Therapeutics Inc is the sale of 12 shares on October 13, 2021, which brought Mark H. Breedlove around $141.
Insider Trading History of Mark H. Breedlove
- 1
Mark H. Breedlove Trading Performance
Mark H. Breedlove Ownership Network
Ownership Network List of Mark H. Breedlove
Ownership Network Relation of Mark H. Breedlove
Mark H. Breedlove Owned Company Details
What does Cognition Therapeutics Inc do?
Who are the key executives at Cognition Therapeutics Inc?
Mark H. Breedlove is the director of Cognition Therapeutics Inc. Other key executives at Cognition Therapeutics Inc include director & CEO & President Lisa Ricciardi , Chief Financial Officer John Brendan Doyle , and Chief Medical Officer Anthony Caggiano .
Cognition Therapeutics Inc (CGTX) Insider Trades Summary
Over the past 18 months, Mark H. Breedlove made no insider transaction in Cognition Therapeutics Inc (CGTX). Other recent insider transactions involving Cognition Therapeutics Inc (CGTX) include a net purchase of 5,700 shares made by Lisa Ricciardi ,
In summary, during the past 3 months, insiders sold 0 shares of Cognition Therapeutics Inc (CGTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cognition Therapeutics Inc (CGTX) were sold and 5,700 shares were bought by its insiders, resulting in a net purchase of 5,700 shares.
Cognition Therapeutics Inc (CGTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cognition Therapeutics Inc Insider Transactions
Mark H. Breedlove Mailing Address
Above is the net worth, insider trading, and ownership report for Mark H. Breedlove. You might contact Mark H. Breedlove via mailing address: C/o Cognition Therapeutics, Inc., 2500 Westchester Ave., Purchase Ny 10577.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
